Shun Yu

45 Changchun St
Beijing, 100053, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy.

Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy.

Journal: Neuropsychiatric disease and treatment

Published: October 16, 2024

Increased α-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease.

Increased α-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease.

Journal: Neuroscience

Published: September 02, 2024

Correlations of erythrocytic oligomer α-synuclein levels with age, sex and clinical variables in patients with Parkinson's disease.

Correlations of erythrocytic oligomer α-synuclein levels with age, sex and clinical variables in patients with Parkinson's disease.

Journal: Frontiers in aging neuroscience

Published: May 24, 2024

Aging-related NADPH diaphorase positive neurodegenerations in the sacral spinal cord of aged non-human primates.

Aging-related NADPH diaphorase positive neurodegenerations in the sacral spinal cord of aged non-human primates.

Journal: Scientific reports

Published: May 15, 2024

Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.

Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.

Journal: Neuroscience

Published: February 06, 2024

Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease.

Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease.

Journal: Neural regeneration research

Published: November 30, 2023

Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells.

Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells.

Journal: Frontiers in aging neuroscience

Published: March 19, 2022

Hemoglobin-binding α-synuclein levels in erythrocytes are elevated in patients with multiple system atrophy.

Hemoglobin-binding α-synuclein levels in erythrocytes are elevated in patients with multiple system atrophy.

Journal: Neuroscience letters

Published: March 06, 2022

Inhibition of α-Synuclein Accumulation Improves Neuronal Apoptosis and Delayed Postoperative Cognitive Recovery in Aged Mice.

Inhibition of α-Synuclein Accumulation Improves Neuronal Apoptosis and Delayed Postoperative Cognitive Recovery in Aged Mice.

Journal: Oxidative medicine and cellular longevity

Published: February 05, 2021

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease.

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease.

Journal: Frontiers in aging neuroscience

Published: October 30, 2020

Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs.

Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs.

Journal: Neuroscience letters

Published: May 26, 2020

Alpha-synuclein differentially reduces surface expression of N-methyl-d-aspartate receptors in the aging human brain.

Alpha-synuclein differentially reduces surface expression of N-methyl-d-aspartate receptors in the aging human brain.

Journal: Neurobiology of aging

Published: October 18, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026